Medicare is offering beneficiaries access to popular obesity drugs for a $50 monthly copay. Patients have to meet certain criteria to qualify. It's a temporary measure that runs through 2027.
Originally reported by NPR. Read the full story at the original source.
Previous advice stressed risks of sleeping in but about 90 minutes extra could prevent high blood pressureFor years, exp...
The discussion about diarrhea has increased lately, especially with the rise of cyclosporiasis. Although unpleasant, it ...
An exam room is seen inside a Planned Parenthood clinic on 10 March 2023. Photograph: Jeff Roberson/APView image in ful...
Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify August 30, 20265:00 AM ET From B...